1308 related articles for article (PubMed ID: 8887370)
21. Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy.
Opstad KS; Murphy MM; Wilkins PR; Bell BA; Griffiths JR; Howe FA
J Magn Reson Imaging; 2004 Aug; 20(2):187-92. PubMed ID: 15269942
[TBL] [Abstract][Full Text] [Related]
22. In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors.
Star-Lack J; Spielman D; Adalsteinsson E; Kurhanewicz J; Terris DJ; Vigneron DB
J Magn Reson; 1998 Aug; 133(2):243-54. PubMed ID: 9716465
[TBL] [Abstract][Full Text] [Related]
23. Functional evaluation of transplanted kidneys by Gd-DTPA enhanced turbo FLASH MR imaging.
Nakashima R; Yamashita Y; Tomiguchi S; Tsuji A; Takahashi M
Radiat Med; 1996; 14(5):251-6. PubMed ID: 8988504
[TBL] [Abstract][Full Text] [Related]
24. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin.
Chernov MF; Ono Y; Kubo O; Hori T
Brain Tumor Pathol; 2006 Apr; 23(1):35-40. PubMed ID: 18095117
[TBL] [Abstract][Full Text] [Related]
26. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.
Sijens PE; van den Bent MJ; Nowak PJ; van Dijk P; Oudkerk M
Magn Reson Med; 1997 Feb; 37(2):222-5. PubMed ID: 9001146
[TBL] [Abstract][Full Text] [Related]
27. Ocular and cerebral metastases in the VX2 rabbit tumor model: contrast-enhanced MR imaging.
Frank JA; Girton M; Dwyer AJ; Cohen PJ; Lightman S; Gansow OA; Brechbiel MW; Doppman JL
Radiology; 1987 Aug; 164(2):527-30. PubMed ID: 3602396
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 1.5T and 3T 1H MR spectroscopy for human brain tumors.
Kim JH; Chang KH; Na DG; Song IC; Kim SJ; Kwon BJ; Han MH
Korean J Radiol; 2006; 7(3):156-61. PubMed ID: 16969044
[TBL] [Abstract][Full Text] [Related]
29. Analysis of brain tumors using 1H magnetic resonance spectroscopy.
McBride DQ; Miller BL; Nikas DL; Buchthal S; Chang L; Chiang F; Booth RA
Surg Neurol; 1995 Aug; 44(2):137-44. PubMed ID: 7502203
[TBL] [Abstract][Full Text] [Related]
30. MRI and MRS of human brain tumors.
Hou BL; Hu J
Methods Mol Biol; 2009; 520():297-314. PubMed ID: 19381963
[TBL] [Abstract][Full Text] [Related]
31. 1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration.
Sijens PE; Oudkerk M; van Dijk P; Levendag PC; Vecht CJ
Magn Reson Imaging; 1998 Dec; 16(10):1273-80. PubMed ID: 9858285
[TBL] [Abstract][Full Text] [Related]
32. Gd-enhanced MR imaging of brain metastases: contrast as a function of dose and lesion size.
Van Dijk P; Sijens PE; Schmitz PI; Oudkerk M
Magn Reson Imaging; 1997; 15(5):535-41. PubMed ID: 9253997
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial.
Negendank W; Sauter R
Anticancer Res; 1996; 16(3B):1533-8. PubMed ID: 8694522
[TBL] [Abstract][Full Text] [Related]
34. Comparison of MR spectroscopy and MR imaging with contrast agent in children with cerebral astrocytomas.
Dezortová M; Hájek M; Cáp F; Babis M; Tichý M; Vymazal J
Childs Nerv Syst; 1999 Aug; 15(8):408-12. PubMed ID: 10447614
[TBL] [Abstract][Full Text] [Related]
35. [Proton-magnetic resonance spectroscopy (1H-MRS) of human plasma obtained from patients with various cancer--new detection method for common cancer].
Itoh YH; Kikuchi A; Kobayashi M; Oguri T
Rinsho Byori; 1995 Dec; 43(12):1279-83. PubMed ID: 8569041
[TBL] [Abstract][Full Text] [Related]
36. In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors.
Gotsis ED; Fountas K; Kapsalaki E; Toulas P; Peristeris G; Papadakis N
Anticancer Res; 1996; 16(3B):1565-7. PubMed ID: 8694527
[TBL] [Abstract][Full Text] [Related]
37. Short-echo time proton MR spectroscopy in the presence of gadolinium.
Lin AP; Ross BD
J Comput Assist Tomogr; 2001; 25(5):705-12. PubMed ID: 11584229
[TBL] [Abstract][Full Text] [Related]
38. Lipids in bone tumors assessed by magnetic resonance: chemical shift imaging and proton spectroscopy in vivo.
Schick F; Duda SH; Lutz O; Claussen CD
Anticancer Res; 1996; 16(3B):1569-74. PubMed ID: 8694528
[TBL] [Abstract][Full Text] [Related]
39. Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?
Baltzer PA; Gussew A; Dietzel M; Rzanny R; Gajda M; Camara O; Reichenbach JR; Kaiser WA
NMR Biomed; 2012 Jan; 25(1):67-74. PubMed ID: 21557368
[TBL] [Abstract][Full Text] [Related]
40. Brain abscess observed by localized proton magnetic resonance spectroscopy.
Harada M; Tanouchi M; Miyoshi H; Nishitani H; Kannuki S
Magn Reson Imaging; 1994; 12(8):1269-74. PubMed ID: 7854033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
